What is he best known for?
The fields of study he is best known for:
Nouri Neamati mostly deals with Integrase, Stereochemistry, Biochemistry, Small molecule and Molecular model.
Nouri Neamati has included themes like Pharmacophore, Docking, Pharmacology and Enzyme in his Integrase study.
His Stereochemistry research incorporates elements of Potency, Chemical synthesis, In vivo and Active site.
His research in Biochemistry intersects with topics in Cancer cell and Cancer.
Nouri Neamati combines subjects such as Molecular biology and STAT3, Signal transduction, Cell biology with his study of Small molecule.
His Molecular model study combines topics from a wide range of disciplines, such as Quantitative structure–activity relationship, Binding site and Biological activity.
His most cited work include:
- Role of the CXCL8-CXCR1/2 axis in cancer and inflammatory diseases (188 citations)
- Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism (188 citations)
- Small Molecule Inhibitors of CXCR4 (182 citations)
What are the main themes of his work throughout his whole career to date?
Integrase, Stereochemistry, Biochemistry, Enzyme and Cancer research are his primary areas of study.
When carried out as part of a general Integrase research project, his work on Hiv 1 integrase is frequently linked to work in Integrase inhibitor, therefore connecting diverse disciplines of study.
His Stereochemistry study integrates concerns from other disciplines, such as Biological activity, Structure–activity relationship and Chemical synthesis.
His Enzyme research includes elements of Lentivirus, Viral replication and Nucleotidyltransferase.
The concepts of his Cancer research study are interwoven with issues in Cancer cell, Cancer, Pancreatic cancer, Cell culture and Cisplatin.
His studies deal with areas such as Drug and Drug discovery as well as Virology.
He most often published in these fields:
- Integrase (42.18%)
- Stereochemistry (30.33%)
- Biochemistry (20.38%)
What were the highlights of his more recent work (between 2012-2020)?
- Cancer research (15.64%)
- Cancer (10.90%)
- Pancreatic cancer (5.69%)
In recent papers he was focusing on the following fields of study:
Nouri Neamati focuses on Cancer research, Cancer, Pancreatic cancer, Pharmacology and Stereochemistry.
His Cancer research study incorporates themes from Cancer cell, Prostate, Prostate cancer and Cell growth.
His Cancer research integrates issues from Cell, Traditional medicine and Immunology.
His Pharmacology study combines topics in areas such as Cell culture and Kinase activity.
His Stereochemistry research incorporates elements of Integrase, Chelation and Active site.
His Integrase research is included under the broader classification of Biochemistry.
Between 2012 and 2020, his most popular works were:
- Role of the CXCL8-CXCR1/2 axis in cancer and inflammatory diseases (188 citations)
- Small Molecule Inhibitors of CXCR4 (182 citations)
- In Vivo Activation of the p53 Tumor Suppressor Pathway by an Engineered Cyclotide. (146 citations)
In his most recent research, the most cited papers focused on:
Nouri Neamati mainly focuses on Biochemistry, Cancer, Integrase, Cell culture and Viral replication.
His Biochemistry study frequently links to related topics such as Cancer therapy.
His research integrates issues of Oxidative phosphorylation, Protein disulfide-isomerase and Immunology in his study of Cancer.
His study in Integrase is interdisciplinary in nature, drawing from both Plasma protein binding, Transcription factor, Peptide sequence, Peptide and Carboxamide.
His work deals with themes such as Active site, Enzyme and Pharmacophore, Natural product, Stereochemistry, which intersect with Viral replication.
His specific area of interest is Stereochemistry, where Nouri Neamati studies Thiazole.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
